In 16S rRNA analysis of bulk stool samples, levels of Actinobacteria (phylum) and Ruminococcus (genus) were higher in the control group than in the IBD patients before anti-TNF-α therapy (V1). The gene discussed is TNF; the disease is inflammatory bowel disease.